Wasatch Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.94M | Buy |
262,045
+4,597
| +2% | +$122K | 0.04% | 172 |
|
|
2025
Q1 | $6.22M | Buy |
257,448
+76,530
| +42% | +$1.85M | 0.03% | 175 |
|
|
2024
Q4 | $7.28M | Sell |
180,918
-46,802
| -21% | -$1.88M | 0.04% | 176 |
|
|
2024
Q3 | $14.4M | Sell |
227,720
-25,449
| -10% | -$1.61M | 0.07% | 138 |
|
|
2024
Q2 | $13.4M | Sell |
253,169
-2,367
| -0.9% | -$125K | 0.07% | 142 |
|
|
2024
Q1 | $21M | Sell |
255,536
-1,019,409
| -80% | -$83.6M | 0.11% | 132 |
|
|
2023
Q4 | $23.7M | Buy |
1,274,945
+311,681
| +32% | +$5.8M | 0.13% | 120 |
|
|
2023
Q3 | $10.7M | Sell |
963,264
-746,211
| -44% | -$8.26M | 0.07% | 143 |
|
|
2023
Q2 | $27.7M | Buy |
1,709,475
+4,031
| +0.2% | +$65.3K | 0.17% | 106 |
|
|
2023
Q1 | $28.4M | Buy |
+1,705,444
| New | +$28.4M | 0.18% | 106 |
|